(VIANEWS) – NASDAQ Composite opens in less than two hours and Xenetic Biosciences‘s pre-market value is already 6.6% down.
The last session, NASDAQ Composite ended with Xenetic Biosciences (XBIO) jumping 65.11% to $5.30. NASDAQ Composite rose 0.11% to $14,778.26, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session.
Today’s last reported volume for Xenetic Biosciences is 63202752, 746.11% above its average volume of 7469830.
Xenetic Biosciences’s last close was $3.21, 45.13% below its 52-week high of $5.85.
The company’s growth estimates for the ongoing quarter is a negative 6.7% and positive 85% for the next.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $5.30 at 08:18 EST, below its 52-week high of $5.85 and way above its 52-week low of $0.76.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s value is way above its 50-day moving average of $2.10 and way higher than its 200-day moving average of $2.29.
Xenetic Biosciences’s last day, last week, and last month’s current volatility was 1.26%, 7.47%, and 5.85%, respectively.
Xenetic Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 20.48% (day), 25.85% (last week), and 14.50% (last month), respectively.
More news about Xenetic Biosciences (XBIO).